Mupirocin
Back to searchMolecule Structure
Scientific Name
Mupirocin
Description of the Drug
Mupirocin is an antibacterial ointment used to treat impetigo and secondary skin infections caused by Staphylococcus aureus and Streptococcus pyogenes.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00410
http://www.drugbank.ca/drugs/DB00410
Brand Name(s)
Bactroban, Centany, Mupirocin
Company Owner(s)
Teva Pharmaceuticals Usa Inc, Padagis Us Llc, Glaxosmithkline, Glenmark Pharmaceuticals Inc Usa, Aleor Dermaceuticals Ltd, Fougera Pharmaceuticals Inc, Taro Pharmaceuticals Usa Inc, Padagis Israel Pharmaceuticals Ltd, Encube Ethicals Private Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Isoleucyl-tRNA synthetase | SINGLE PROTEIN | INHIBITOR | CHEMBL2364671 |
| Isoleucyl-tRNA synthetase | SINGLE PROTEIN | INHIBITOR | CHEMBL1982 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL3291 | |||
| PharmGKB | PA164764568 | |||
| Human Metabolome Database | HMDB0014554 | |||
| DrugBank | DB00410 | |||
| PubChem: Thomson Pharma | 14859952 | 14933324 | ||
| PubChem | 446596 | |||
| LINCS | LSM-43176 | |||
| Nikkaji | J15.623J | |||
| BindingDB | 50290686 | |||
| EPA CompTox Dashboard | DTXSID0046438 | |||
| DrugCentral | 1857 | |||
| Metabolights | MTBLC7025 | |||
| Brenda | 18240 | |||
| ChemicalBook | CB0689829 | |||
| Guide to Pharmacology | 10916 | |||
| rxnorm | MUPIROCIN CALCIUM | MUPIROCIN | BACTROBAN | CENTANY |
| PubChem: Drugs of the Future | 12013725 | |||
| KEGG Ligand | C11758 | |||
| ChEBI | 7025 | |||
| ZINC | ZINC000004102194 |
